SCHEMBL2653305

SCHEMBL2653305

CC(C)(CCCc1ccc(C(=O)NCCC(=O)O)cc1)COc1ccc(-c2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ GCGR P47871 6/20 0.46
▸ GIPR P48546 1/20 0.45
▸ FFAR1 O14842 2/20 0.45
▸ FFAR4 Q5NUL3 1/20 0.45
▸ EPHX2 P34913 1/20 0.44
▸ PPARA Q07869 4/20 0.44
▸ PPARD Q03181 3/20 0.44
▸ PPARG P37231 2/20 0.44
▸ RXRA P19793 1/20 0.44
▸ NR1H2 P55055 1/20 0.44
▸ S1PR1 P21453 1/20 0.44
▸ ADCY6 O43306 2/20 0.43
▸ ADCY3 O60266 2/20 0.43
▸ ADCY9 O60503 2/20 0.43
▸ ADCY5 O95622 2/20 0.43
▸ ADCY8 P40145 2/20 0.43
▸ ADCY7 P51828 2/20 0.43
▸ ADCY2 Q08462 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2661394 0.92 MEN1 (0.48) MEN1KMT2APPARAPPARDMAPK14
SCHEMBL2656186 0.90 GCG (0.49) MEN1KMT2AGCGRGIPRPPARA
SCHEMBL2654727 0.89 GCGR (0.55) MEN1KMT2AGCGRGIPREPHX2
SCHEMBL2656558 0.87 GCGR (0.45) GCGRGIPRPPARAPPARD
SCHEMBL2653326 0.87 MEN1 (0.57) MEN1KMT2AGCGRGIPRFFAR1
SCHEMBL2652593 0.87 MEN1 (0.57) MEN1KMT2AGCGRGIPRFFAR1
SCHEMBL2655721 0.86 MEN1 (0.56) MEN1KMT2AGCGRGIPRFFAR1
SCHEMBL2651906 0.86 MEN1 (0.56) MEN1KMT2AGCGRGIPRFFAR1
SCHEMBL2652886 0.85 MEN1 (0.55) MEN1KMT2AGCGRGIPRFFAR1
SCHEMBL2652235 0.85 MEN1 (0.55) MEN1KMT2AGCGRGIPRFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758853-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 — — EP claimed
WO-2005123668-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-29 — — WO claimed
EP-1758853-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 — — EP disclosed
WO-2005123668-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-29 — — WO disclosed
Send feedback